Search Results 1631-1640 of 21946 for Inhibition

1. Low-Dose Selinexor and Choline Salicylate for the Treatment of Patients With Non-Hodgkin Lymphoma or Histiocytic/Dendritic Cell Neoplasms - Mayo Clinic

   - Prior exposure to a selective inhibitors of nuclear export (SINE) compound, including selinexor - Receiving any other investigational agent which would be ...

2. Publications - Lance C. Pagliaro, M.D. - Mayo Clinic

   ... Inhibitor Therapy: A Multicenter Analysis. Eur Urol 2025 Aug; 88 (2):212-214 ... Inhibitors in Clinical Trials: A Systematic Review and Meta-analysis.

3. Breast Clinic - Clinical trials

   ... inhibitor. In the phase II part, to evaluate the preliminary antitumor activity of two different doses/regimens of [177Lu]Lu-NeoB in combination with ...

4. A study assessing esophageal function and remodeling with dupilumab compared with placebo for 24 weeks followed by 104 weeks open-label in adult participants with EoE - Mayo Clinic

   Proton pump inhibitors (except for participants who require a PPI treatment prior to baseline endoscopy);; Leukotriene inhibitors;; Nasal and/or inhaled ...

5. Brentuximab Vedotin or Crizotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II-IV Anaplastic Large Cell Lymphoma - Mayo Clinic

   CYP3A4 inhibitors: patients chronically receiving drugs that are known potent CYP3A4 inhibitors within 7 days prior to study enrollment, including but not ...

6. Clinical trials - Oncology (Medical)

   ... inhibitor, crizotinib. After enrollment, patients will receive one cycle of Induction chemotherapy. Subsequent therapy will be based upon MIBG avidity and ...

7. A Study of the Effects of Decreasing the Lasix Dose on the Cardiorenal System - Mayo Clinic

   On stable doses of an ACE inhibitor, beta blocker, digoxin, furosemide, or angiotensin II receptor type 1 blocker over the past 3 months; No episode of ...

8. A Study to Evaluate Ruxolitinib for the Treatment of Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplant - Mayo Clinic

   Previous allergic reactions to Janus kinase (JAK) inhibitors or excipients. ... Concomitant use of any JAK inhibitor. - Initiating therapy with any ...

9. MC230813 A Study of Golcadomide with Rituximab prior to CAR-T with Relapsed or Primary Refractory Aggressive B-cell Non-Hodgkin Lymphoma (NHL) - Mayo Clinic

   Full anticoagulation is defined as Warfarin, factor X inhibitors, or low molecular weight heparin at therapeutic doses. The rationale for this requirement ...

10. Inpatient, Dose-Ranging Study of Staccato Alprazolam in Epilepsy With Predictable Seizure Pattern - Mayo Clinic

    ... inhibitors (e.g., ritonavir). Has severe chronic cardio-respiratory disease. History of HIV-positivity. Pregnant or breast-feeding. Clinically significant ...